Effects of dopaminergic treatment on putaminal dopamine turnover measured with 18F-Dopa-PET in Parkinson's disease

被引:0
|
作者
Wolz, M. [1 ]
Beuthien-Baumann, B. [2 ]
Loehle, M. [1 ]
Herting, B. [1 ]
Oehme, L. [2 ]
van den Hoff, J. [3 ]
Perick, M. [2 ]
Kotzerke, J. [2 ]
Reichmann, H. [1 ]
Storch, A. [1 ]
机构
[1] Tech Univ Dresden, Dept Neurol, Dresden, Germany
[2] Tech Univ Dresden, Dept Nucl Med, Dresden, Germany
[3] Forschungszentrum Dresden Rossendorf, Positron Emiss Tomog Div, Dresden, Germany
关键词
D O I
10.1016/S1353-8020(09)70222-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1.100
引用
收藏
页码:S54 / S55
页数:2
相关论文
共 50 条
  • [31] Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study.
    Bossert, I.
    Morbelli, S.
    Piccardo, A.
    Marinelli, L.
    Picco, A.
    Buschiazzo, A.
    Arnaldi, D.
    Ferrara, M.
    Brugnolo, A.
    Iacozzi, M.
    Villavecchia, G.
    Sambuceti, G.
    Abbruzzese, G.
    Nobili, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S183 - S183
  • [32] Contralateral Posterior Putaminal 18F-Fluorodopa Uptake in Mild Stage Parkinson's Disease: A PET/CT Study
    Zhou, Lei-Lei
    Wang, Si-Yu
    Tian, You-Yong
    Jiang, Teng
    Chen, Yu-Chen
    Huang, Ting
    Zhang, Ying-Dong
    Wang, Feng
    CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (04) : 465 - 469
  • [33] Compensatory changes in the globus pallidus in early Parkinson's disease:: An 18F-DOPA PET study
    Whone, AL
    Moore, RY
    Piccini, P
    Brooks, DJ
    NEUROLOGY, 2001, 56 (08) : A72 - A73
  • [34] Automated Striatal Analysis of 18F-DOPA PET images of patients with suspected Parkinson's Disease
    Fahmi, R.
    Platsch, G.
    Schiazza, A.
    Koulibaly, M.
    Zuehlsdorff, S.
    Darcourt, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S301 - S301
  • [35] Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET
    Hardie, RJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02): : 256 - 256
  • [36] Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson's disease
    Schiepers, Christiaan
    Silverman, Daniel
    Dahlbom, Magnus
    Czernin, Johannes
    Phelps, Michael
    Huang, Sung-Cheng
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [37] 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease
    Ceravolo, R
    Piccini, P
    Bailey, DL
    Jorga, KM
    Bryson, H
    Brooks, DJ
    SYNAPSE, 2002, 43 (03) : 201 - 207
  • [38] Putaminal dopamine turnover in de novo Parkinson's disease predicts levodopa-induced motor complications
    Loehle, M.
    Mende, J.
    Wolz, M.
    Beuthien-Baumann, B.
    Oehme, L.
    van den Hoff, J.
    Kotzerke, J.
    Reichmann, H.
    Storch, A.
    MOVEMENT DISORDERS, 2015, 30 : S13 - S14
  • [39] Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease
    Pikstra, Angelina R. A.
    van der Hoorn, Anouk
    Leenders, Klaus L.
    de Jong, Bauke M.
    NEUROIMAGE-CLINICAL, 2016, 11 : 68 - 72
  • [40] Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET
    Morrish, PK
    Rakshi, JS
    Bailey, DL
    Sawle, GV
    Brooks, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03): : 314 - 319